Roivant Sciences Ltd Cash Flow-to-Debt Ratio
Roivant Sciences Ltd cash flow-to-debt ratio. Roivant Sciences Ltd (ROIV) has a Cash Flow-to-Debt Ratio of -0.78x as of December 2025, meaning its operating cash flow of $-196.48 Million could theoretically repay -1% of its total liabilities ($251.14 Million) in one year. Check Roivant Sciences Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Roivant Sciences Ltd (2019–2025)
Cash flow-to-debt ratio of Roivant Sciences Ltd from 2019 to 2025. Historical debt coverage capacity for Roivant Sciences Ltd across 7 annual periods. Also explore net asset momentum of Roivant Sciences Ltd to track the company's year-over-year net asset growth rate.
Roivant Sciences Ltd Cash Flow-to-Debt Ratio by Year (2019–2025)
Roivant Sciences Ltd cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Roivant Sciences Ltd. For the full cash flow conversion analysis, see ROIV cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.36x | $-839.45 Million | $249.74 Million | ▼ -239.9% |
| 2024 | -0.99x | $-765.27 Million | $773.95 Million | ▲ +8.3% |
| 2023 | -1.08x | $-843.39 Million | $782.02 Million | ▲ +16.7% |
| 2022 | -1.29x | $-677.73 Million | $523.70 Million | ▼ -23.7% |
| 2021 | -1.05x | $-552.14 Million | $527.69 Million | ▲ +49.4% |
| 2020 | -2.07x | $-761.83 Million | $368.36 Million | ▲ +9.0% |
| 2019 | -2.27x | $-1.02 Billion | $450.51 Million | — |